Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

摘要

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effects of aspirin or heparin (including low‐molecular‐weight heparins), or both for improving pregnancy outcome in women with persistent (on two occasions not less than 12 weeks apart) APLA, either LAC, aCL or aβ2 antibodies or a combination and recurrent pregnancy loss (miscarriage or fetal loss).